Valuation
- Market cap
- 61,608,000
- Revenue TTM
- $16,640,000
- Net income TTM
- $-9,980,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -59.98%
- Debt to equity
- 0.24
Trading
- Volume
- 3,761
- Avg volume
- 723,276
- Day's range
- $1.29 – $1.42
- Shares out
- 47,391,000
- Stochastic %K
- 42%
- Beta
- -2.31
- Analysts
- —
- Price target
- —
Company profile
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabie...
Show more
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 86 432 6304 7008
- Website
- https://www.jlzybio.com
- Address
- No.1 Lianmeng Road, Jilin Eco & Technical Dev Zn, Jilin, China
Latest news
No headlines yet.
